The new Israeli technology allows for the creation of hundreds of cornea implants from a single donor sample, offering a scalable solution.
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the U.S. Food and Drug ...
The Journal on MSN
Man jailed for Dublin nightclub attack
A man who smashed a pint glass into the face of another man in a Dublin nightclub, causing serious eye injuries, has been ...
Precise Bio has reported the first successful human implantation of its 3D-printed cornea implant, constructed of functional ...
A Utah man shares how a donated cornea restored his vision and inspired him to help others during National Eye Donation Month ...
Precise Bio has successfully treated a patient with PB-001, the company’s 3D-bio-printed corneal implant, at Rambam Medical ...
Ptosis and strabismus rarely occur after glaucoma surgery, but they predominantly occur after surgery involving muscle ...
Conversely, patients with low risk for graft failure can be discharged from the care of their transplant nephrologist and ...
Approval based on results of landmark Phase 3 C-POST trial that show Libtayo is first immunotherapy to significantly improve disease-free ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the European Commission (EC) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback